{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T03:11:29Z","timestamp":1785208289134,"version":"3.55.0"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T00:00:00Z","timestamp":1716508800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Multiple Myeloma (MM) is classified as one of the most challenging cancers to diagnose, and the hematological malignancy is associated with prolonged diagnostic delays. Although major steps have been made in the improvement of MM patient diagnosis and care, Romanian patients still face long diagnostic delays. Thus far, there have been no studies evaluating the factors associated with diagnostic errors in Romanian MM patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Using the Aarhus statement, we prospectively determined the diagnostic intervals for 103 patients diagnosed with MM at Fundeni Clinical Institute, between January 2022 and March 2023.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Our data revealed that the main diagnostic delays are experienced during the \u201cpatient interval.\u201d Patients spend a median of 162 days from the first symptom onset until the first doctor appointment. Bone pain is the most frequently reported symptom by patients (78.64%), but it leads to a medical-seeking behavior in only half of the reporting patients and results in a median delay of 191 days. The changes in routine lab tests are considered most worrisome for patients, leading to a medical appointment after a median of only 25 days. The median primary care interval was 70 days, with patients having an average of 3.7 medical visits until MM suspicion was first raised. The secondary care interval did not contribute to the diagnostic delays.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Overall, the median diagnostic path for MM patients in Romania was more than 6 months, leading to a higher number of emergency presentations and myeloma-related end-organ damage.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2024.1372907","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T11:53:18Z","timestamp":1716551598000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Determining diagnostic delays in Romanian multiple myeloma patients using the Aarhus statement"],"prefix":"10.3389","volume":"11","author":[{"given":"Ruxandra","family":"Irimia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sorina","family":"Badelita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinziana","family":"Barbu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana Loredana","family":"Cirlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa","family":"Zidaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Coriu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,5,24]]},"reference":[{"key":"ref1","first-page":"1","volume-title":"Improving diagnosis in health care","year":"2016"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1136\/thx.2004.029264","article-title":"Is late diagnosis of lung cancer inevitable? Interview study of patients\u2019 recollections of symptoms before diagnosis","volume":"60","author":"Corner","year":"2005","journal-title":"Thorax"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1515\/DX-2021-0092","article-title":"Diagnostic delays in infectious diseases","volume":"9","author":"Suneja","year":"2022","journal-title":"Diagnosis"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1515\/dx-2019-0104","article-title":"Rate of diagnostic errors and serious misdiagnosis-related harms for major vascular events, infections, and cancers: toward a national incidence estimate using the \u201cbig three\u201d","volume":"8","author":"Newman-Toker","year":"2021","journal-title":"Diagnosi"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/BJH.14513","article-title":"Multiple myeloma: routes to diagnosis, clinical characteristics and survival \u2013 findings from a UK population-based study","volume":"177","author":"Howell","year":"2017","journal-title":"Br J Haematol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2147\/CEOR.S132259","article-title":"A retrospective analysis of delays in the diagnosis of lung cancer and associated costs","volume":"9","author":"Gildea","year":"2017","journal-title":"Clin Outcomes Res"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"IJH13","DOI":"10.2217\/ijh-2018-0014","article-title":"Methods for reducing delays in the diagnosis of multiple myeloma","volume":"8","author":"Koshiaris","year":"2019","journal-title":"Int J Hematol Oncol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"e347","DOI":"10.3399\/BJGP.2020.0697","article-title":"Clinical prediction tools to identify patients at highest risk of myeloma in primary care: a retrospective open cohort study","volume":"71","author":"Koshiaris","year":"2021","journal-title":"Br J Gen Pract"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/2052-1839-13-9","article-title":"Time-to-diagnosis and symptoms of myeloma, lymphomas and leukaemias: a report from the Haematological malignancy research network","volume":"13","author":"Howell","year":"2013","journal-title":"BMC Hematol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.3399\/bjgp15X683545","article-title":"Quantifying the risk of multiple myeloma from symptoms reported in primary care patients: a large case-control study using electronic records","volume":"65","author":"Shephard","year":"2015","journal-title":"Br J Gen Pract"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"e0194788","DOI":"10.1371\/journal.pone.0194788","article-title":"Myeloma: patient accounts of their pathways to diagnosis","volume":"13","author":"Howell","year":"2018","journal-title":"PLoS One"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1080\/10428190902741471","article-title":"Diagnostic delay and complications for older adults with multiple myeloma","volume":"50","author":"Friese","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"ref13","article-title":"Multiple myeloma: Clinical features, laboratory manifestations, and diagnosis","year":""},{"key":"ref14","article-title":"Multiple myeloma","year":""},{"key":"ref15","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1186\/s12885-021-08280-y","article-title":"Measuring the global, regional, and national burden of multiple myeloma from 1990 to 2019","volume":"21","author":"Zhou","year":"2021","journal-title":"BMC Cancer"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"e1406","DOI":"10.1634\/THEONCOLOGIST.2020-0141","article-title":"Multiple myeloma incidence and mortality around the globe; interrelations between health access and quality, economic resources, and patient empowerment","volume":"25","author":"Ludwig","year":"2020","journal-title":"Oncologist"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12913-018-3476-0\/TABLES\/2","article-title":"The Aarhus statement on cancer diagnostic research: turning recommendations into new survey instruments","volume":"18","author":"Coxon","year":"2018","journal-title":"BMC Health Serv Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/bjc.2012.68","article-title":"The Aarhus statement: improving design and reporting of studies on early cancer diagnosis","volume":"106","author":"Weller","year":"2012","journal-title":"Br J Cancer"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S1470-2045(12)70041-4","article-title":"Variation in number of general practitioner consultations before hospital referral for cancer: findings from the 2010 National Cancer Patient Experience Survey in England","volume":"13","author":"Lyratzopoulos","year":"2012","journal-title":"Lancet Oncol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"S84","DOI":"10.1038\/bjc.2015.47","article-title":"Understanding missed opportunities for more timely diagnosis of cancer in symptomatic patients after presentation","volume":"112","author":"Lyratzopoulos","year":"2015","journal-title":"Br J Cancer"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1080\/10428194.2020.1849681","article-title":"Interdisciplinary approach to multiple myeloma - time to diagnosis and warning signs","volume":"62","author":"Herget","year":"2021","journal-title":"Leuk Lymphoma"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1002\/cncr.31237","article-title":"Trends in multiple myeloma presentation, management, cost of care, and outcomes in the Medicare population: a comprehensive look at racial disparities","volume":"124","author":"Ailawadhi","year":"2018","journal-title":"Cancer"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/bjc.2013.1","article-title":"Measures of promptness of cancer diagnosis in primary care: secondary analysis of national audit data on patients with 18 common and rarer cancers","volume":"108","author":"Lyratzopoulos","year":"2013","journal-title":"Br J Cancer"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12913-022-08457-6\/FIGURES\/2","article-title":"Increased healthcare costs by later stage cancer diagnosis","volume":"22","author":"McGarvey","year":"2022","journal-title":"BMC Health Serv Res"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1136\/bmj.g7400","article-title":"Rethinking diagnostic delay in cancer: how difficult is the diagnosis?","volume":"349","author":"Lyratzopoulos","year":"2014","journal-title":"BMJ"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1372907\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T11:53:22Z","timestamp":1716551602000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1372907\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,24]]},"references-count":25,"alternative-id":["10.3389\/fmed.2024.1372907"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1372907","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,24]]},"article-number":"1372907"}}